panchkula
+916284828066
+916284828066

CEFITYN-200 Tablet CEFITYN-200 is a pharmaceutical product marketed by Medroots Biopharma Pvt. Ltd....

CEFITYN-200 Tablet CEFITYN-200 is a pharmaceutical product marketed by Medroots Biopharma Pvt. Ltd.. The product is available across PAN India and is also offered through Chandigarh PCD Pharma Franchise opportunities. Composition Cefixime 200 mg Therapeutic Category Antibiotic Tablet Third-Generation Cephalosporin Uses of CEFITYN-200 CEFITYN-200 is commonly prescribed for the treatment of bacterial infections such as: Respiratory tract infections Throat and tonsil infections Urinary tract infections (UTI) Ear infections Sinus infections Bronchitis and pneumonia Typhoid fever Cefixime works by inhibiting bacterial cell wall synthesis, helping eliminate infection-causing bacteria. Benefits Broad-spectrum antibacterial action Effective against various bacterial infections Helps provide rapid symptomatic relief Widely used oral antibiotic formulation Possible Side Effects Some commonly reported side effects may include: Nausea Diarrhoea Stomach pain Indigestion Vomiting Use only under medical supervision and complete the full prescribed antibiotic course. Storage Store in a cool and dry place Protect from moisture and direct sunlight PAN India Availability CEFITYN-200 is available for: PAN India pharmaceutical distribution Retail and wholesale supply Institutional and hospital supply Third-party pharma business opportunities Chandigarh PCD Pharma Franchise Medroots Biopharma Pvt. Ltd. offers: Chandigarh PCD Pharma Franchise Monopoly rights Distributor opportunities Promotional and marketing support Franchise business across Chandigarh, Mohali, Panchkula, and all over India The company operates from Panchkula, Haryana and provides franchise and distribution services nationwide. Company Contact Information Official Contact Page Medroots Biopharma (India) Pvt. Ltd. Plot No. 17, Industrial Area, Phase-1, Panchkula, Haryana Phone: +91-62848-28066 Email: medrootsindia@gmail.com
 2026-05-20T07:20:27

Keywords